Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
High-Density Lipoprotein-Cholesterol Functionality and Metabolic Syndrome: Protocol for Review and Meta-Analysis Publisher Pubmed



Roever L1 ; Resende ES1 ; Diniz ALD1 ; Penhasilva N1 ; Oconnell JL1 ; Gomes PFS1 ; Zanetti HR1, 2 ; Roerverborges AS2 ; Veloso FC1 ; De Souza FR1 ; Duarte PRA1 ; Fidale TM1 ; Casellafilho A3 ; Dourado PMM3 Show All Authors
Authors
  1. Roever L1
  2. Resende ES1
  3. Diniz ALD1
  4. Penhasilva N1
  5. Oconnell JL1
  6. Gomes PFS1
  7. Zanetti HR1, 2
  8. Roerverborges AS2
  9. Veloso FC1
  10. De Souza FR1
  11. Duarte PRA1
  12. Fidale TM1
  13. Casellafilho A3
  14. Dourado PMM3
  15. Chagas ACP3, 4
  16. Alihasanalsaegh S5
  17. Reis PEO6
  18. De Melo Costa Pinto R1
  19. Oliveira GBF7
  20. Avezum A7
  21. Neto M8
  22. Duraes AR8
  23. Da Silva RMFL9
  24. Grande AJ10
  25. Denardi C11
  26. Lopes RD12
  27. Nerlekar N13
  28. Alizadeh S14
  29. Hernandez AV15
  30. Da Rosa MI16
  31. Biondizoccai G17

Source: Medicine (United States) Published:2018


Abstract

Introduction: The prevalence of metabolic syndrome (MetS) and MetS-related stroke is set to increase dramatically in coming decades. MetS is a complex disease that includes endothelial dysfunction, insulin resistance, diabetes, hypertension, ectopic obesity, and dyslipidaemia and an increased risk of cardiovascular events. One function of high-density lipoprotein (HDL) cholesterol (HDL-C) is the cholesterol-efflux pathway, which is the pathway where cholesterol is removed from macrophages within the arterial walls back into the bloodstream and out to the liver. As one of the key functions of HDL, their hypothesis was that if they could measure HDL-C-efflux capacity, they would have a better handle on the role of HDL in atherosclerosis. However, there are no systematic analyses or well-conducted meta-analyses to evaluate the relationship between HDL-C functionality and MetS. The aim of this study is to examine this association of HDL-C functionality with MetS in different ages and sex. Methods and analysis: The update systematic review and meta-analysis will be conducted using published studies that will be identified from electronic databases (i.e., PubMed, EMBASE, Web of Science, and Google Scholar). Studies that examined the association between HDL-C functionality and MetS; focused on cohort, case-control, and cross-sectional studies; were conducted among in adults aged 40 to 70 years; provided sufficient data for calculating odds ratio or relative risk with a 95% confidence interval; were published as original articles written in English or other languages; and have been published until January 2018 will be included. Study selection, data collection, quality assessment, and statistical syntheses will be conducted based on discussions among investigators. Ethics and dissemination: Ethics approval was not required for this study because it was based on published studies. The results and findings of this study will be submitted and published in a scientific peer-reviewed journal. Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc.
Other Related Docs